Share Price | PetVivo Holdings, Inc. Stock Analysis & Recommendation

Q: What does PetVivo Holdings, Inc. do?

Overview:PetVivo Holdings, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:Most recent Net Sales: 1 Million (Quarterly Results - Dec 2024) Most recent Net Profit: -2 Million (Quarterly Results - Dec 2024) Market-cap: USD 16.49 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.48 Return on Equity: 863.13% Price to Book: -16.49Contact Details:Registrar Address: Not available.

Q: Is PetVivo Holdings, Inc. technically bullish or bearish?

As of 1 October 2023, the technical data for PetVivo Holdings, Inc. is insufficient to form a view on whether it is bullish or bearish.

Q: Is PetVivo Holdings, Inc. overvalued or undervalued?

As of 5 October 2023, PetVivo Holdings, Inc. has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 15%. In comparison to its peers, PetVivo's P/E ratio is lower than that of VetPartners, which stands at 15.2, and it also outperforms Animal Health Corp with a P/B ratio of 2.5. This suggests that PetVivo is trading at a discount relative to its industry counterparts. Additionally, the company's recent stock performance has shown resilience against the Sensex, reinforcing the notion that it is undervalued in the current market landscape.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.35 k

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

98.93%

Held by 1 DIIs

Promoter

0.00%

What does PetVivo Holdings, Inc. do?

22-Jun-2025

PetVivo Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $2 million as of December 2024, with a market cap of $16.49 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of 863.13%.

View full answer

Is PetVivo Holdings, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for PetVivo Holdings, Inc. to determine a bullish or bearish outlook.

View full answer

Is PetVivo Holdings, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, PetVivo Holdings, Inc. is considered attractive and undervalued, with a P/E ratio of 12.5 and a P/B ratio of 1.8, both lower than its peers, indicating it is trading at a discount relative to the industry.

View full answer

Compare PetVivo Holdings, Inc. with Similar Stocks

Sientra, Inc.PAVmed, Inc.LumiraDX Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Flat results in Jun 25

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 33 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.20

Return on Equity

-218.38%

Price to Book

7.87

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Sep 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

53.64%

6 Months

90.96%

1 Year

36.29%

2 Years

-58.98%

3 Years

-58.58%

4 Years

-91.91%

5 Years

-50.87%

PetVivo Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

18.13%

EBIT Growth (5y)

-215.69%

EBIT to Interest (avg)

-6.92

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.41

Sales to Capital Employed (avg)

0.71

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.70%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-18.38

EV to EBIT

-2.26

EV to EBITDA

-2.29

EV to Capital Employed

19.85

EV to Sales

19.85

PEG Ratio

Dividend Yield

ROCE (Latest)

-880.28%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.07%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.00% vs 50.00% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -30.43% vs 4.17% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.90",
          "val2": "-1.70",
          "chgp": "-11.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.10",
          "chgp": "800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.00",
          "val2": "-2.30",
          "chgp": "-30.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,810.00%",
          "val2": "-6,199.40%",
          "chgp": "-61.06%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.00% vs 11.11% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 23.64% vs -26.44% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.10",
          "val2": "1.00",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.70",
          "val2": "-10.50",
          "chgp": "26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.40",
          "val2": "-11.00",
          "chgp": "23.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-7,113.00%",
          "val2": "-10,964.50%",
          "chgp": "385.15%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

0.30

Operating Profit (PBDIT) excl Other Income

-1.90

-1.70

-11.76%

Interest

0.90

0.10

800.00%

Exceptional Items

0.00

-0.30

100.00%

Consolidate Net Profit

-3.00

-2.30

-30.43%

Operating Profit Margin (Excl OI)

-6,810.00%

-6,199.40%

-61.06%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 50.00% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -30.43% vs 4.17% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1.10

1.00

10.00%

Operating Profit (PBDIT) excl Other Income

-7.70

-10.50

26.67%

Interest

0.40

0.00

Exceptional Items

-0.00

-0.30

100.00%

Consolidate Net Profit

-8.40

-11.00

23.64%

Operating Profit Margin (Excl OI)

-7,113.00%

-10,964.50%

385.15%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 10.00% vs 11.11% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 23.64% vs -26.44% in Mar 2024

All Annual Results

Company CV

About PetVivo Holdings, Inc.

PetVivo Holdings, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

PetVivo Holdings, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

What does PetVivo Holdings, Inc. do?

Watch in Real-Time

Is PetVivo Holdings, Inc. technically bullish or bearish?

Is PetVivo Holdings, Inc. overvalued or undervalued?

Compare PetVivo Holdings, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Flat results in Jun 25

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Annual Results Snapshot (Consolidated) - Mar'25

About PetVivo Holdings, Inc.

Company Coordinates